Randomized Phase II Trial of Nintedanib, Afatinib and Sequential Combination in Castration-Resistant Prostate Cancer
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Future Oncology
DOI: 10.2217/fon.13.250
Authors: L Rhoda Molife, Aurelius Omlin, Rob J Jones, Vasilios Karavasilis, David Bloomfield, Graeme Lumsden, Peter C Fong, David Olmos, Joe M O‘Sullivan, Ian Pedley, Tamas Hickish, Peter Jenkins, Emilda Thompson, Nikhil Oommen, Duncan Wheatley, Catherine Heath, Graham Temple, Katy Pelling, Johann S de Bono
Institutions: Institute of Cancer Research, Royal Marsden Hospital, Beatson West of Scotland Cancer Centre, Cancer Research UK, Royal Sussex County Hospital, Queen's University Belfast, Freeman Hospital, Sir Bobby Robson Foundation, Royal Bournemouth Hospital, Bournemouth University, Cheltenham General Hospital, Royal Cornwall Hospital, Southampton General Hospital, Boehringer Ingelheim (United Kingdom)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2126318680